Last week, the D.C. Circuit Court of Appeals (the “Court”) reinstated a rule cutting reimbursement rates for drugs purchased at a substantial discount under Section 340B of the Public Health Service Act (the “340B Program”) that had previously been ruled unenforceable by the District Court. In American Hospital Association v. Azar,[1] the Court held... READ MORE
D.C. Circuit Upholds 340B Drug Reimbursement Cuts: Is This the End of the Road?
Posted on August 7, 2020 in Health Law News
Published by: Hall Render
